Vericel Corp. (VCEL)
35.12
-0.28
(-0.79%)
USD |
NASDAQ |
May 21, 16:00
35.12
0.00 (0.00%)
After-Hours: 19:59
Vericel Shareholders Equity (Quarterly) : 356.23M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 13.80M |
| Arbutus Biopharma Corp. | 260.18M |
| Tenaya Therapeutics, Inc. | 106.19M |
| Moderna, Inc. | 7.408B |
| Curis, Inc. | 12.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 485.63M |
| Total Liabilities (Quarterly) | 129.40M |
| Debt to Equity Ratio | 0.2707 |
| Current Ratio | 5.176 |
| Net Debt Paydown Yield | 0.04% |